New Articles

  1. Can MBG be used for islands in an archipelago community?

    This would depend entirely on the spatial relationship of trachoma amongst the different islands.   If there was strong spatial correlation between islands it may be possible to use MBG, however this would need to be reviewed on a case-by-cas...
  2. Can MBG be used when there is large population movement?

    When there is large population movement within an EU, one of the challenges for the models is trying to incorporate more assumptions and to account for more variation than normal, and this leads to a lot of uncertainty. It may be possible to accou...
  3. Can MBG be used to estimate prevalence in inaccessible EUs?

    MBG has not yet been used to estimate prevalence in inaccessible EUs, however, it is theoretically possible to do this when there are enough existing data in nearby EUs to estimate trachoma prevalence in the area of interest. There would need to b...
  4. Do more or fewer clusters need to be visited when using the MBG approach for survey design?

    Past research in both trachoma and other neglected tropical diseases (NTDs), such as soil-transmitted helminthiases and lymphatic filariasis, has shown that MBG requires fewer clusters compared to the standard survey design. This is because MBG ta...
  5. What is required in order to run MBG?

    Permission to use country-specific prevalence data is needed, with access provided to the individual-level data contained in all relevant datasets. The surveys must have been supported by the Global Trachoma Mapping Project (GTMP) and/or Tropical ...
  6. How has MBG been used so far within the context of trachoma elimination?

    To date, MBG has been used to create a geostatistical survey design to quantify the likelihood that TT prevalence at EU-level is below the TT elimination threshold (See publications folder for relevant papers supporting this). It has also been use...
  7. Does MBG replace the need for surveys?

    No, surveys will still be required in most cases as some data are always needed to run the models.   The more data that are available, the better the predictive ability of the model.
  8. How will the PBT threshold be decided?

    Setting the PBT threshold is a decision that is both political and technical, as it is a question about how much uncertainty the global trachoma community is willing to tolerate. A special advisory group (SAG) is in the process of being created, l...
  9. What is the Probability of being Below Threshold (PBT)?

    The PBT is the probability of being below the elimination threshold: a prevalence of less than 5% for trachomatous inflammation—follicular (TF), or less than 0.2% for trachomatous trichiasis (TT). As PBT values get closer to 100% or 0%, we c...
  10. How is MBG different from the current method for estimating trachoma prevalence?

    MBG uses a model-based approach, whereas the current Tropical Data method uses a design-based approach, to estimate trachoma prevalence. The current design-based approach uses prevalence data and the population census from a single evaluation unit...